Sarah Elizabeth Turbett, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anaplasma phagocytophilum | 3 | 2022 | 37 | 2.130 |
Why?
|
Enterobacteriaceae | 5 | 2023 | 161 | 1.510 |
Why?
|
Anaplasmosis | 2 | 2022 | 37 | 1.450 |
Why?
|
Exanthema | 5 | 2024 | 502 | 1.270 |
Why?
|
Syphilis | 2 | 2024 | 243 | 1.190 |
Why?
|
Borrelia | 2 | 2023 | 66 | 1.060 |
Why?
|
Anti-Infective Agents | 2 | 2023 | 983 | 1.020 |
Why?
|
Feces | 5 | 2024 | 1510 | 0.870 |
Why?
|
Hafnia | 1 | 2023 | 3 | 0.870 |
Why?
|
Lyme Disease | 3 | 2024 | 629 | 0.850 |
Why?
|
Borrelia burgdorferi | 2 | 2024 | 183 | 0.810 |
Why?
|
Enterobacteriaceae Infections | 3 | 2023 | 190 | 0.790 |
Why?
|
Arthritis | 2 | 2024 | 684 | 0.720 |
Why?
|
Sin Nombre virus | 1 | 2020 | 3 | 0.710 |
Why?
|
Hantavirus Pulmonary Syndrome | 1 | 2020 | 11 | 0.710 |
Why?
|
Antibodies, Viral | 7 | 2022 | 3216 | 0.690 |
Why?
|
Ehrlichiosis | 1 | 2020 | 28 | 0.690 |
Why?
|
Coccidioidomycosis | 1 | 2020 | 36 | 0.680 |
Why?
|
Drug Resistance, Bacterial | 4 | 2023 | 1063 | 0.670 |
Why?
|
Specimen Handling | 2 | 2024 | 708 | 0.670 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 192 | 0.670 |
Why?
|
Bites and Stings | 1 | 2020 | 94 | 0.650 |
Why?
|
Lung Diseases, Fungal | 1 | 2020 | 124 | 0.640 |
Why?
|
Pancytopenia | 1 | 2020 | 102 | 0.640 |
Why?
|
Organ Transplantation | 3 | 2023 | 1176 | 0.620 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2020 | 249 | 0.600 |
Why?
|
Roseolovirus Infections | 1 | 2018 | 50 | 0.600 |
Why?
|
Herpesvirus 6, Human | 1 | 2018 | 97 | 0.590 |
Why?
|
Glomerulonephritis | 1 | 2020 | 333 | 0.580 |
Why?
|
Tenosynovitis | 1 | 2017 | 57 | 0.570 |
Why?
|
Leptospirosis | 1 | 2017 | 45 | 0.550 |
Why?
|
Antifungal Agents | 1 | 2022 | 761 | 0.540 |
Why?
|
Aortitis | 2 | 2014 | 77 | 0.530 |
Why?
|
Diagnosis, Differential | 10 | 2024 | 13000 | 0.530 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2020 | 238 | 0.520 |
Why?
|
Fever | 6 | 2022 | 1613 | 0.500 |
Why?
|
Communicable Diseases | 1 | 2023 | 874 | 0.480 |
Why?
|
Neisseria gonorrhoeae | 1 | 2017 | 249 | 0.470 |
Why?
|
Lung | 5 | 2022 | 10094 | 0.450 |
Why?
|
beta-Lactamases | 6 | 2023 | 307 | 0.450 |
Why?
|
Arthritis, Infectious | 1 | 2017 | 348 | 0.440 |
Why?
|
Serologic Tests | 3 | 2024 | 382 | 0.430 |
Why?
|
Endocarditis, Bacterial | 2 | 2014 | 436 | 0.420 |
Why?
|
Gonorrhea | 1 | 2017 | 355 | 0.420 |
Why?
|
Klebsiella Infections | 2 | 2024 | 146 | 0.410 |
Why?
|
Sepsis | 2 | 2024 | 2608 | 0.410 |
Why?
|
Dyspnea | 1 | 2020 | 1352 | 0.390 |
Why?
|
Immunoglobulin M | 4 | 2024 | 1527 | 0.380 |
Why?
|
Colistin | 2 | 2023 | 46 | 0.380 |
Why?
|
Travel | 4 | 2023 | 805 | 0.360 |
Why?
|
Antibodies, Bacterial | 3 | 2024 | 1478 | 0.330 |
Why?
|
Aorta | 2 | 2014 | 2045 | 0.330 |
Why?
|
Staphylococcal Infections | 2 | 2014 | 1398 | 0.300 |
Why?
|
Decision Making | 1 | 2022 | 3952 | 0.300 |
Why?
|
Aortic Valve | 2 | 2014 | 1970 | 0.280 |
Why?
|
Cough | 2 | 2022 | 598 | 0.280 |
Why?
|
Lymph Nodes | 1 | 2018 | 3472 | 0.270 |
Why?
|
Myocardium | 1 | 2020 | 4788 | 0.270 |
Why?
|
Humans | 52 | 2024 | 767991 | 0.260 |
Why?
|
Klebsiella pneumoniae | 2 | 2024 | 253 | 0.250 |
Why?
|
Diarrhea | 2 | 2022 | 1320 | 0.240 |
Why?
|
Pneumonia | 3 | 2022 | 2163 | 0.240 |
Why?
|
Bacteremia | 2 | 2024 | 986 | 0.240 |
Why?
|
Immunoglobulin G | 4 | 2024 | 4564 | 0.240 |
Why?
|
Serotyping | 1 | 2024 | 331 | 0.220 |
Why?
|
Skin | 2 | 2014 | 4503 | 0.220 |
Why?
|
Antibodies, Neutralizing | 3 | 2022 | 2011 | 0.220 |
Why?
|
Central Nervous System Infections | 1 | 2024 | 61 | 0.210 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 2024 | 48 | 0.210 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2024 | 238 | 0.210 |
Why?
|
O Antigens | 1 | 2024 | 196 | 0.210 |
Why?
|
Sensitivity and Specificity | 6 | 2024 | 14718 | 0.210 |
Why?
|
Bedding and Linens | 1 | 2023 | 41 | 0.210 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 168 | 0.190 |
Why?
|
Radiography, Thoracic | 2 | 2020 | 1321 | 0.190 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7939 | 0.190 |
Why?
|
Anti-Bacterial Agents | 7 | 2024 | 7470 | 0.190 |
Why?
|
Peromyscus | 1 | 2020 | 16 | 0.180 |
Why?
|
Fatal Outcome | 3 | 2020 | 1836 | 0.180 |
Why?
|
Transplants | 1 | 2022 | 208 | 0.170 |
Why?
|
Bone Marrow Examination | 1 | 2020 | 154 | 0.170 |
Why?
|
Patient Isolation | 1 | 2020 | 101 | 0.170 |
Why?
|
Escherichia coli | 2 | 2023 | 4215 | 0.160 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2023 | 3813 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 621 | 0.160 |
Why?
|
Malacoplakia | 1 | 2019 | 15 | 0.160 |
Why?
|
Microbial Viability | 1 | 2020 | 237 | 0.160 |
Why?
|
Microbial Sensitivity Tests | 2 | 2023 | 1967 | 0.160 |
Why?
|
Blood Cell Count | 1 | 2020 | 406 | 0.160 |
Why?
|
Carbapenems | 1 | 2020 | 125 | 0.160 |
Why?
|
Chills | 1 | 2018 | 17 | 0.160 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 412 | 0.160 |
Why?
|
Leukocytosis | 1 | 2020 | 251 | 0.160 |
Why?
|
Lung Transplantation | 2 | 2019 | 1309 | 0.150 |
Why?
|
Culture Media | 1 | 2020 | 898 | 0.150 |
Why?
|
Immune Evasion | 1 | 2022 | 375 | 0.150 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 365 | 0.150 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2020 | 219 | 0.150 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.150 |
Why?
|
Infectious Disease Incubation Period | 1 | 2017 | 16 | 0.150 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1150 | 0.150 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2020 | 760 | 0.140 |
Why?
|
Acute Kidney Injury | 2 | 2020 | 1942 | 0.140 |
Why?
|
Indonesia | 1 | 2017 | 131 | 0.140 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2022 | 618 | 0.140 |
Why?
|
Tretinoin | 1 | 2020 | 524 | 0.140 |
Why?
|
Thorax | 1 | 2020 | 557 | 0.140 |
Why?
|
Genome, Viral | 1 | 2020 | 674 | 0.140 |
Why?
|
Candida | 1 | 2017 | 173 | 0.130 |
Why?
|
Syphilis Serodiagnosis | 1 | 2016 | 37 | 0.130 |
Why?
|
Disease Outbreaks | 2 | 2023 | 1761 | 0.130 |
Why?
|
Leukocyte Count | 1 | 2020 | 1609 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.120 |
Why?
|
Synovial Fluid | 1 | 2017 | 393 | 0.120 |
Why?
|
Algorithms | 4 | 2024 | 14163 | 0.120 |
Why?
|
Candidiasis | 1 | 2017 | 367 | 0.120 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2016 | 133 | 0.120 |
Why?
|
Cross Infection | 1 | 2024 | 1426 | 0.120 |
Why?
|
Middle Aged | 12 | 2024 | 223422 | 0.120 |
Why?
|
Thrombocytopenia | 2 | 2020 | 1179 | 0.110 |
Why?
|
Ankle | 1 | 2017 | 353 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1162 | 0.110 |
Why?
|
Bronchoscopy | 1 | 2020 | 913 | 0.110 |
Why?
|
Gait Disorders, Neurologic | 1 | 2016 | 243 | 0.110 |
Why?
|
Abdomen | 1 | 2020 | 1137 | 0.110 |
Why?
|
Temperature | 1 | 2020 | 2234 | 0.110 |
Why?
|
Edema | 1 | 2017 | 765 | 0.110 |
Why?
|
Immunocompromised Host | 1 | 2019 | 863 | 0.110 |
Why?
|
Arthritis, Psoriatic | 1 | 2016 | 219 | 0.110 |
Why?
|
Phylogeny | 1 | 2020 | 2843 | 0.100 |
Why?
|
RNA | 1 | 2023 | 2718 | 0.100 |
Why?
|
Uveitis | 1 | 2016 | 398 | 0.100 |
Why?
|
Male | 14 | 2024 | 364641 | 0.100 |
Why?
|
Hand | 1 | 2017 | 913 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 3 | 2020 | 20757 | 0.100 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1240 | 0.090 |
Why?
|
New England | 2 | 2024 | 1058 | 0.080 |
Why?
|
Headache | 1 | 2017 | 1263 | 0.080 |
Why?
|
Cross Reactions | 2 | 2022 | 828 | 0.080 |
Why?
|
Tissue and Organ Procurement | 1 | 2017 | 986 | 0.080 |
Why?
|
Vision Disorders | 1 | 2016 | 1093 | 0.080 |
Why?
|
Hearing Loss | 1 | 2016 | 785 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2271 | 0.080 |
Why?
|
Retrospective Studies | 6 | 2024 | 81746 | 0.080 |
Why?
|
Genotype | 1 | 2022 | 13042 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6786 | 0.070 |
Why?
|
Mass Screening | 1 | 2022 | 5458 | 0.060 |
Why?
|
Ultrasonography | 1 | 2018 | 6004 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2019 | 3301 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15442 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20218 | 0.050 |
Why?
|
Monkeypox virus | 1 | 2023 | 43 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Pain | 1 | 2017 | 5100 | 0.050 |
Why?
|
Female | 9 | 2024 | 397113 | 0.050 |
Why?
|
beta-Lactams | 1 | 2023 | 158 | 0.050 |
Why?
|
Young Adult | 2 | 2020 | 60048 | 0.050 |
Why?
|
Coloring Agents | 1 | 2023 | 565 | 0.050 |
Why?
|
Ritonavir | 1 | 2023 | 331 | 0.050 |
Why?
|
Immunoassay | 1 | 2024 | 746 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 404 | 0.040 |
Why?
|
Drug Resistance, Microbial | 1 | 2023 | 830 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2023 | 794 | 0.040 |
Why?
|
Metagenomics | 1 | 2024 | 474 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2016 | 4573 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 665 | 0.040 |
Why?
|
Metagenome | 1 | 2023 | 465 | 0.040 |
Why?
|
HIV Infections | 2 | 2016 | 17569 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 54924 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 40214 | 0.040 |
Why?
|
North America | 1 | 2022 | 1289 | 0.040 |
Why?
|
Hepatic Encephalopathy | 1 | 2019 | 144 | 0.040 |
Why?
|
United States | 5 | 2024 | 73027 | 0.040 |
Why?
|
Animals | 2 | 2020 | 169222 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2020 | 339 | 0.040 |
Why?
|
Hospitals | 2 | 2022 | 3886 | 0.040 |
Why?
|
Bacterial Proteins | 2 | 2022 | 3841 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 648 | 0.040 |
Why?
|
Boston | 2 | 2020 | 9368 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2022 | 1951 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13658 | 0.030 |
Why?
|
Seasons | 1 | 2023 | 1524 | 0.030 |
Why?
|
Immunoglobulin A | 1 | 2020 | 991 | 0.030 |
Why?
|
Syndrome | 1 | 2023 | 3271 | 0.030 |
Why?
|
JC Virus | 1 | 2016 | 87 | 0.030 |
Why?
|
Adult | 4 | 2024 | 223583 | 0.030 |
Why?
|
Heart Failure | 1 | 2020 | 11883 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2526 | 0.030 |
Why?
|
Polysaccharides | 1 | 2022 | 1024 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59598 | 0.030 |
Why?
|
Rocky Mountain Spotted Fever | 1 | 2014 | 19 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2022 | 1896 | 0.030 |
Why?
|
Mice | 1 | 2020 | 82024 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3210 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8748 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5402 | 0.020 |
Why?
|
Confusion | 1 | 2014 | 278 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3669 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2216 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2783 | 0.020 |
Why?
|
Massachusetts | 1 | 2023 | 8888 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2024 | 5349 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7213 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 2596 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9343 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2019 | 1399 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2679 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3385 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2014 | 812 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5925 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2014 | 1096 | 0.020 |
Why?
|
Mutation | 2 | 2023 | 30211 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2016 | 1903 | 0.020 |
Why?
|
Aged | 4 | 2020 | 171446 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 74936 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2014 | 1430 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15867 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8507 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4415 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26375 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36534 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10840 | 0.010 |
Why?
|
Kidney | 1 | 2014 | 7065 | 0.010 |
Why?
|
HIV-1 | 1 | 2016 | 6960 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41749 | 0.010 |
Why?
|